Albendazole: a new drug for human parasitoses (Q35131556)

6 August 2017

1 reference

title

Albendazole: a new drug for human parasitoses (English)

1 reference

6 August 2017

Giancarlo Albanese

1

1 reference

PubMed ID

12757251

6 August 2017

Caterina Venturi

series ordinal

2

1 reference

6 August 2017

1 April 2003

1 reference

6 August 2017

1 reference

6 August 2017

21

1 reference

6 August 2017

2

1 reference

6 August 2017

283-290

1 reference

Oral albendazole for the treatment of cutaneous larva migrans

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Creeping eruption stopped in its tracks by albendazole

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Albendazole therapy and reduced decline in haemoglobin concentration during pregnancy (Sierra Leone).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Albendazole as a potential treatment for human hydatidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Intestinal helminth infections, anaemia and labour productivity of female tea pluckers in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

The effect of different anthelmintic treatment regimens combined with iron supplementation on the nutritional status of schoolchildren in KwaZulu-Natal, South Africa: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Non-invasive management of Ascaris lumbricoides biliary tact migration: a prospective study in 69 patients from Ecuador

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Late onset temporal lobe epilepsy with MRI evidence of mesial temporal sclerosis following acute neurocysticercosis: case report

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Medullary gnathostomiasis in a white patient: use of immunodiagnosis and magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Therapy for human gastrointestinal microsporidiosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Chemotherapy of enterobiasis (oxyuriasis).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Albendazole therapy for loiasis refractory to diethylcarbamazine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Ultrasound appearance of preclinical Oesophagostomum bifurcum induced colonic pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

The effect of albendazole on Oesophagostomum bifurcum infection and pathology in children from rural northern Ghana

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Pilot study of albendazole in patients with advanced malignancy. Effect on serum tumor markers/high incidence of neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

In vitro and in vivo suppression of growth of hepatocellular carcinoma cells by albendazole

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Single dose of albendazole in the treatment of cutaneous larva migrans

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Treatment of ocular toxocariasis with albendazole

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Albendazole treatment of children with ascariasis enhances the vibriocidal antibody response to the live attenuated oral cholera vaccine CVD 103-HgR

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Persistent cutaneous larva migrans due to Ancylostoma species

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

Cutaneous larva migrans contracted in England: a reminder

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2802%2900085-2

7 January 2021

10.1016/S0733-8635(02)00085-2

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12757251